All bills
H.Con.Res. 107·108th Congress·House Concurrent Resolution

Urging increased Federal funding for juvenile (Type 1) diabetes research.

Stage not supplied

The source supplies the latest action, but no lifecycle stage.

Latest action (10 Apr 2003): Referred to the Subcommittee on Health.

What this bill does

This bill, H.Con.Res. 107, is a concurrent resolution introduced in the House of Representatives. It urges an increase in federal funding for research into juvenile (Type 1) diabetes. The resolution states that over one million Americans have this chronic disease, with thousands of children and adults diagnosed annually. It highlights that current treatments manage the condition but do not cure it or prevent serious complications like blindness or kidney failure.

The bill specifically references recommendations from the Diabetes Research Working Group, a nonpartisan advisory board. This group has called for an accelerated and expanded diabetes research program at the National Institutes of Health, suggesting a $4.1 billion increase in federal funding over five years. The resolution aims to support finding a cure for juvenile diabetes.

H.Con.Res. 107 was introduced in the House of Representatives in March 2003. Its latest action noted is that it was referred to the Subcommittee on Health in April 2003. As a concurrent resolution, if passed by both the House and Senate, it would express the sense of Congress to the executive branch, but it does not have the force of law.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Timeline

  1. 10 Apr 2003

    Referred to the Subcommittee on Health.

Common questions

What does H.Con.Res. 107 do?
This bill, H.Con.Res. 107, is a concurrent resolution introduced in the House of Representatives. It urges an increase in federal funding for research into juvenile (Type 1) diabetes. The resolution states that over one million Americans have this chronic disease, with thousands of children and adults diagnosed annually. It highlights that current treatments manage the condition but do not cure it or prevent serious complications like blindness or kidney failure. The bill specifically references recommendations from the Diabetes Research Working Group, a nonpartisan advisory board. This group has called for an accelerated and expanded diabetes research program at the National Institutes of Health, suggesting a $4.1 billion increase in federal funding over five years. The resolution aims to support finding a cure for juvenile diabetes. H.Con.Res. 107 was introduced in the House of Representatives in March 2003. Its latest action noted is that it was referred to the Subcommittee on Health in April 2003. As a concurrent resolution, if passed by both the House and Senate, it would express the sense of Congress to the executive branch, but it does not have the force of law.
Has H.Con.Res. 107 become law?
The source does not supply a confirmed lifecycle stage for H.Con.Res. 107. Check the latest action and official source below.
Who sponsored H.Con.Res. 107?
H.Con.Res. 107 was sponsored by Rep. Green, Gene [D-TX-29] (D-TX), with 45 cosponsors.
What's the latest action on H.Con.Res. 107?
Referred to the Subcommittee on Health. (10 Apr 2003).

Related bills in Health

More bills from Rep. Green, Gene [D-TX-29]

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.